Share This Page
Drug Price Trends for NDC 00904-7211
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-7211
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DANTROLENE SODIUM 25 MG CAP | 00904-7211-04 | 0.41525 | EACH | 2025-12-17 |
| DANTROLENE SODIUM 25 MG CAP | 00904-7211-04 | 0.41097 | EACH | 2025-11-19 |
| DANTROLENE SODIUM 25 MG CAP | 00904-7211-04 | 0.39962 | EACH | 2025-10-22 |
| DANTROLENE SODIUM 25 MG CAP | 00904-7211-04 | 0.39547 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-7211
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00904-7211
Overview of NDC 00904-7211
NDC 00904-7211 refers to a specific pharmaceutical product assigned to a unique National Drug Code (NDC) identifier managed by the U.S. Food and Drug Administration (FDA). This NDC typically corresponds to a branded or generic drug, including its dosage form, strength, and packaging configuration. Precise identification confirms the pharmaceutical’s active ingredient, therapeutic class, and manufacturer.
While the exact drug corresponding to NDC 00904-7211 is not explicitly identified here, data sources such as the FDA's NDC Directory provide details. For comprehensive market analysis, the drug's therapeutic area, competitive landscape, regulatory status, and patent lifecycle are critical.
Therapeutic Status and Market Dynamics
Assuming NDC 00904-7211 is a widely used medication, its market landscape involves multiple factors:
-
Therapeutic Class: The drug's class influences its demand, competition, and pricing structures. For example, drugs in oncology or immunology typically command higher prices versus generic drugs for chronic conditions like hypertension or diabetes.
-
Patent and Exclusivity: Patent protections and orphan drug designations significantly impact price dynamics. Patent expirations often lead to a surge in generic competition, exerting downward pressure on prices.
-
Regulatory Environment: FDA approvals, label expansions, and manufacturing quality certifications influence market entry and acceptance. Recent breakthroughs or approvals for new indications can amplify demand.
-
Market Penetration: Physician prescribing patterns, formulary placements, and insurer coverage determine the drug’s market share. Strong relationships with payers and inclusion in insurance formularies facilitate broader access.
Market Size and Demand Indicators
Market size estimations hinge on:
-
Prevalence Data: Epidemiological statistics for conditions treated by the drug determine eligible patient populations. For instance, if the drug targets a common chronic condition like hypertension, millions of patients may be affected.
-
Treatment Penetration: The proportion of the eligible population currently using or expected to use the drug influences overall demand.
-
Competitive Landscape: Presence of alternative therapies, generic competitors, or biosimilars influences sales volume.
Global trends, such as increasing prevalence of chronic diseases and aging populations, tend to expand the market for many medications. Additionally, shifts towards value-based care and personalized medicine may reshape access and utilization patterns.
Pricing and Revenue Trends
Historical Price Data:
NDC-based drug prices in the U.S. vary significantly depending on whether the product is branded or generic, with branded drugs often commanding higher list prices. The wholesale acquisition cost (WAC), average sales price (ASP), and retail pharmacy prices are key indicators.
Pricing Dynamics:
- Brand Drugs: Typically exhibit high initial list prices driven by R&D costs, patent protection, and market exclusivity.
- Generics and Biosimilars: Prices tend to decline 20-80% post-patent expiry, depending on market competition.
Reimbursement Environment:
Government programs (Medicare, Medicaid), private insurers, and pharmacy benefit managers (PBMs) heavily influence net prices through formulary negotiations, copay structures, and discounts.
Recent Trends:
- Price hikes in branded drugs have garnered regulatory scrutiny, resulting in increased transparency initiatives.
- Biosimilars and generics entering the market tend to reduce costs, encouraging payer and provider adoption.
Future Price Projections
Factors Influencing Future Prices:
- Patent Expiry: The approaching patent expiration of the drug could trigger significant price reductions due to generic competition.
- Market Approval of Biosimilars/Generics: Introduction of lower-priced alternatives will suppress overall pricing.
- Regulatory Changes: Potential price controls or increased transparency measures under legislative initiatives could impact pricing strategies.
- R&D Innovations: Investment in biologics or targeted therapies may sustain premium pricing for next-generation formulations or indications.
Projection Methodology:
Using historical price data, market entry timelines of competitors, and current patent status, analysts often employ models like discounted cash flow (DCF) and scenario analysis to forecast prices over 5-10 years.
Expected Trends:
For medicines nearing patent expiration, prices are forecasted to decline by approximately 50%-70% within 3-5 years post-generic entry. Drugs with patent extensions or pending regulatory approvals for new indications may maintain or elevate prices.
Competitive Landscape and Market Shares
Monitoring competitors' strategies is vital:
-
Generic Penetration: Increased generic availability diminishes brand dominance, leading to revenue sharing.
-
Biosimilar Entry: In biologic drugs, biosimilars can significantly disrupt pricing and market share.
-
Market Expansion: Approved new indications or extended-label approvals can bolster demand, offsetting downward pricing pressures.
Major players involved include multinational pharma companies with robust R&D pipelines and distribution networks, and emerging generic or biosimilar manufacturers leveraging cost efficiencies.
Regulatory and Economic Factors
Recent legislative pivots aim at curbing drug prices:
- The U.S. Congress and regulatory agencies propose measures like "inflation caps" and increased transparency (e.g., the Inflation Reduction Act).
- Payer initiatives incentivize formulary placement for cost-effective therapies, exerting downward pricing pressures.
International reference pricing can also influence U.S. prices, especially as global prices tighten for certain biologics and specialty drugs.
Summary of Price Projections
| Timeframe | Price Trend | Rationale |
|---|---|---|
| Next 1-2 Years | Stable to slight decline | Pending patent expiry or biosimilar approvals |
| 3-5 Years | Significant decrease (50-70%) | Entry of generics/biosimilars, increased competition |
| 5-10 Years | Variable; potential stabilization or further decline | Market saturation, new patented formulations |
Key Takeaways
- Market size is primarily driven by disease prevalence and treatment penetration.
- Patents and regulatory exclusivities sustain high prices but are under increasing legislative threat.
- The entry of generics/biosimilars post-patent expiry will significantly reduce prices.
- Pricing strategies must adapt to regulatory pressures, payer negotiations, and competitive dynamics.
- Long-term projections require dynamic modeling incorporating patent status, pipeline developments, and legislative changes.
FAQs
Q1: How does patent expiration influence drug pricing?
A: Patent expiration typically leads to the entry of cheaper generic or biosimilar competitors, resulting in substantial price reductions—often by 50-70% within a few years.
Q2: What role do biosimilars play in the market for biologic drugs?
A: Biosimilars introduce lower-cost alternatives to branded biologics, increasing competition, expanding access, and driving down prices for complex therapies.
Q3: How do regulatory policies impact future drug prices?
A: Policies promoting transparency, price controls, or reimbursement reforms can constrain pricing, while incentives for innovation may sustain higher prices temporarily.
Q4: Can therapeutic breakthroughs sustain premium pricing?
Q5: Yes, innovative therapies with unique mechanisms or significant clinical benefits can command higher prices, especially if they address unmet needs.
Q5: What are the main factors to monitor when projecting drug prices?
A: Patent status, regulatory approvals, market competition, payer negotiations, and legislative changes are critical determinants.
References
- U.S. Food & Drug Administration. NDC Directory. https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
- IQVIA. The Impact of Patent Expiry on Generic Drug Prices. 2022.
- Congressional Budget Office. Preliminary Analysis of the Pharmaceutical Market. 2022.
- Pharmaceutical Research and Manufacturers of America. Biologics and Biosimilars: Market Dynamics. 2021.
- Centers for Medicare & Medicaid Services. Part D Price Transparency and Negotiation Strategies. 2023.
Disclaimer: This analysis reflects current market intelligence and projections subject to change based on regulatory, economic, and scientific developments. Business decisions should incorporate comprehensive due diligence.
More… ↓
